Table of Content

1 Osteoarthritis Pain Drugs Market Overview
1.1 Osteoarthritis Pain Drugs Product Scope
1.2 Osteoarthritis Pain Drugs Segment by Type
1.2.1 Global Osteoarthritis Pain Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Osteoarthritis Pain Drugs Segment by Application
1.3.1 Global Osteoarthritis Pain Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Osteoarthritis Pain Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Osteoarthritis Pain Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Osteoarthritis Pain Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Osteoarthritis Pain Drugs Price Trends (2016-2027)

2 Osteoarthritis Pain Drugs Estimates and Forecasts by Region
2.1 Global Osteoarthritis Pain Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Osteoarthritis Pain Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Osteoarthritis Pain Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Osteoarthritis Pain Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Osteoarthritis Pain Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Osteoarthritis Pain Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Osteoarthritis Pain Drugs Estimates and Projections (2016-2027)
2.4.3 China Osteoarthritis Pain Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Osteoarthritis Pain Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Osteoarthritis Pain Drugs Estimates and Projections (2016-2027)
2.4.6 India Osteoarthritis Pain Drugs Estimates and Projections (2016-2027)
3 Global Osteoarthritis Pain Drugs Competition Landscape by Players
3.1 Global Top Osteoarthritis Pain Drugs Players by Sales (2016-2021)
3.2 Global Top Osteoarthritis Pain Drugs Players by Revenue (2016-2021)
3.3 Global Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Osteoarthritis Pain Drugs as of 2020)
3.4 Global Osteoarthritis Pain Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Osteoarthritis Pain Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Osteoarthritis Pain Drugs Market Size by Type
4.1 Global Osteoarthritis Pain Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Osteoarthritis Pain Drugs Price by Type (2016-2021)
4.2 Global Osteoarthritis Pain Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Osteoarthritis Pain Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Osteoarthritis Pain Drugs Price Forecast by Type (2022-2027)
5 Global Osteoarthritis Pain Drugs Market Size by Application
5.1 Global Osteoarthritis Pain Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Osteoarthritis Pain Drugs Price by Application (2016-2021)
5.2 Global Osteoarthritis Pain Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Osteoarthritis Pain Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Osteoarthritis Pain Drugs Price Forecast by Application (2022-2027)

6 North America Osteoarthritis Pain Drugs Market Facts & Figures
6.1 North America Osteoarthritis Pain Drugs Sales by Company
6.1.1 North America Osteoarthritis Pain Drugs Sales by Company (2016-2021)
6.1.2 North America Osteoarthritis Pain Drugs Revenue by Company (2016-2021)
6.2 North America Osteoarthritis Pain Drugs Sales Breakdown by Type
6.2.1 North America Osteoarthritis Pain Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Osteoarthritis Pain Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Osteoarthritis Pain Drugs Sales Breakdown by Application
6.3.1 North America Osteoarthritis Pain Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Osteoarthritis Pain Drugs Sales Breakdown by Application (2022-2027)

7 Europe Osteoarthritis Pain Drugs Market Facts & Figures
7.1 Europe Osteoarthritis Pain Drugs Sales by Company
7.1.1 Europe Osteoarthritis Pain Drugs Sales by Company (2016-2021)
7.1.2 Europe Osteoarthritis Pain Drugs Revenue by Company (2016-2021)
7.2 Europe Osteoarthritis Pain Drugs Sales Breakdown by Type
7.2.1 Europe Osteoarthritis Pain Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Osteoarthritis Pain Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Osteoarthritis Pain Drugs Sales Breakdown by Application
7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)

8 China Osteoarthritis Pain Drugs Market Facts & Figures
8.1 China Osteoarthritis Pain Drugs Sales by Company
8.1.1 China Osteoarthritis Pain Drugs Sales by Company (2016-2021)
8.1.2 China Osteoarthritis Pain Drugs Revenue by Company (2016-2021)
8.2 China Osteoarthritis Pain Drugs Sales Breakdown by Type
8.2.1 China Osteoarthritis Pain Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Osteoarthritis Pain Drugs Sales Breakdown by Type (2022-2027)
8.3 China Osteoarthritis Pain Drugs Sales Breakdown by Application
8.3.1 China 311 Sales Breakdown by Application (2016-2021)
8.3.2 China 311 Sales Breakdown by Application (2022-2027)

9 Japan Osteoarthritis Pain Drugs Market Facts & Figures
9.1 Japan Osteoarthritis Pain Drugs Sales by Company
9.1.1 Japan Osteoarthritis Pain Drugs Sales by Company (2016-2021)
9.1.2 Japan Osteoarthritis Pain Drugs Revenue by Company (2016-2021)
9.2 Japan Osteoarthritis Pain Drugs Sales Breakdown by Type
9.2.1 Japan Osteoarthritis Pain Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Osteoarthritis Pain Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Osteoarthritis Pain Drugs Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Osteoarthritis Pain Drugs Market Facts & Figures
10.1 Southeast Asia Osteoarthritis Pain Drugs Sales by Company
10.1.1 Southeast Asia Osteoarthritis Pain Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Osteoarthritis Pain Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Osteoarthritis Pain Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Osteoarthritis Pain Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Osteoarthritis Pain Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Osteoarthritis Pain Drugs Sales Breakdown by Application
10.3.1 Southeast Asia M Dose Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Dose Sales Breakdown by Application (2022-2027)

11 India Osteoarthritis Pain Drugs Market Facts & Figures
11.1 India Osteoarthritis Pain Drugs Sales by Company
11.1.1 India Osteoarthritis Pain Drugs Sales by Company (2016-2021)
11.1.2 India Osteoarthritis Pain Drugs Revenue by Company (2016-2021)
11.2 India Osteoarthritis Pain Drugs Sales Breakdown by Type
11.2.1 India Osteoarthritis Pain Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Osteoarthritis Pain Drugs Sales Breakdown by Type (2022-2027)
11.3 India Osteoarthritis Pain Drugs Sales Breakdown by Application
11.3.1 India Osteoarthritis Pain Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Osteoarthritis Pain Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Osteoarthritis Pain Drugs Business
12.1 Sino Biopharmaceutical
12.1.1 Sino Biopharmaceutical Corporation Information
12.1.2 Sino Biopharmaceutical Business Overview
12.1.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sino Biopharmaceutical Osteoarthritis Pain Drugs Products Offered
12.1.5 Sino Biopharmaceutical Recent Development
12.2 Chugai Pharmaceutical
12.2.1 Chugai Pharmaceutical Corporation Information
12.2.2 Chugai Pharmaceutical Business Overview
12.2.3 Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Chugai Pharmaceutical Osteoarthritis Pain Drugs Products Offered
12.2.5 Chugai Pharmaceutical Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer Osteoarthritis Pain Drugs Products Offered
12.3.5 Pfizer Recent Development
12.4 Mikasa Seiyaku
12.4.1 Mikasa Seiyaku Corporation Information
12.4.2 Mikasa Seiyaku Business Overview
12.4.3 Mikasa Seiyaku Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Mikasa Seiyaku Osteoarthritis Pain Drugs Products Offered
12.4.5 Mikasa Seiyaku Recent Development
12.5 Bayer
12.5.1 Bayer Corporation Information
12.5.2 Bayer Business Overview
12.5.3 Bayer Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bayer Osteoarthritis Pain Drugs Products Offered
12.5.5 Bayer Recent Development
12.6 Haohai Biological
12.6.1 Haohai Biological Corporation Information
12.6.2 Haohai Biological Business Overview
12.6.3 Haohai Biological Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Haohai Biological Osteoarthritis Pain Drugs Products Offered
12.6.5 Haohai Biological Recent Development
12.7 SK Chemicals
12.7.1 SK Chemicals Corporation Information
12.7.2 SK Chemicals Business Overview
12.7.3 SK Chemicals Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 SK Chemicals Osteoarthritis Pain Drugs Products Offered
12.7.5 SK Chemicals Recent Development
12.8 Taisho Pharmaceutical
12.8.1 Taisho Pharmaceutical Corporation Information
12.8.2 Taisho Pharmaceutical Business Overview
12.8.3 Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Taisho Pharmaceutical Osteoarthritis Pain Drugs Products Offered
12.8.5 Taisho Pharmaceutical Recent Development
12.9 Zhejiang Chengyi Pharmaceutical
12.9.1 Zhejiang Chengyi Pharmaceutical Corporation Information
12.9.2 Zhejiang Chengyi Pharmaceutical Business Overview
12.9.3 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Products Offered
12.9.5 Zhejiang Chengyi Pharmaceutical Recent Development
12.10 Freda
12.10.1 Freda Corporation Information
12.10.2 Freda Business Overview
12.10.3 Freda Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Freda Osteoarthritis Pain Drugs Products Offered
12.10.5 Freda Recent Development
12.11 Bright Future
12.11.1 Bright Future Corporation Information
12.11.2 Bright Future Business Overview
12.11.3 Bright Future Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Bright Future Osteoarthritis Pain Drugs Products Offered
12.11.5 Bright Future Recent Development
12.12 Jingfeng Pharmaceutical
12.12.1 Jingfeng Pharmaceutical Corporation Information
12.12.2 Jingfeng Pharmaceutical Business Overview
12.12.3 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Products Offered
12.12.5 Jingfeng Pharmaceutical Recent Development
12.13 Seikagaku Corporation
12.13.1 Seikagaku Corporation Corporation Information
12.13.2 Seikagaku Corporation Business Overview
12.13.3 Seikagaku Corporation Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Seikagaku Corporation Osteoarthritis Pain Drugs Products Offered
12.13.5 Seikagaku Corporation Recent Development
12.14 GSK
12.14.1 GSK Corporation Information
12.14.2 GSK Business Overview
12.14.3 GSK Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 GSK Osteoarthritis Pain Drugs Products Offered
12.14.5 GSK Recent Development
12.15 Sanofi
12.15.1 Sanofi Corporation Information
12.15.2 Sanofi Business Overview
12.15.3 Sanofi Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Sanofi Osteoarthritis Pain Drugs Products Offered
12.15.5 Sanofi Recent Development
12.16 Crystal Genomics
12.16.1 Crystal Genomics Corporation Information
12.16.2 Crystal Genomics Business Overview
12.16.3 Crystal Genomics Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Crystal Genomics Osteoarthritis Pain Drugs Products Offered
12.16.5 Crystal Genomics Recent Development
12.17 Johnson & Johnson
12.17.1 Johnson & Johnson Corporation Information
12.17.2 Johnson & Johnson Business Overview
12.17.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Johnson & Johnson Osteoarthritis Pain Drugs Products Offered
12.17.5 Johnson & Johnson Recent Development
12.18 GlaxoSmithKline
12.18.1 GlaxoSmithKline Corporation Information
12.18.2 GlaxoSmithKline Business Overview
12.18.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.18.4 GlaxoSmithKline Osteoarthritis Pain Drugs Products Offered
12.18.5 GlaxoSmithKline Recent Development
12.19 Mylan
12.19.1 Mylan Corporation Information
12.19.2 Mylan Business Overview
12.19.3 Mylan Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Mylan Osteoarthritis Pain Drugs Products Offered
12.19.5 Mylan Recent Development
12.20 Lilly
12.20.1 Lilly Corporation Information
12.20.2 Lilly Business Overview
12.20.3 Lilly Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Lilly Osteoarthritis Pain Drugs Products Offered
12.20.5 Lilly Recent Development
12.21 Abbott Laboratories
12.21.1 Abbott Laboratories Corporation Information
12.21.2 Abbott Laboratories Business Overview
12.21.3 Abbott Laboratories Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Abbott Laboratories Osteoarthritis Pain Drugs Products Offered
12.21.5 Abbott Laboratories Recent Development
12.22 Almatica Pharma
12.22.1 Almatica Pharma Corporation Information
12.22.2 Almatica Pharma Business Overview
12.22.3 Almatica Pharma Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Almatica Pharma Osteoarthritis Pain Drugs Products Offered
12.22.5 Almatica Pharma Recent Development
12.23 TEVA
12.23.1 TEVA Corporation Information
12.23.2 TEVA Business Overview
12.23.3 TEVA Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.23.4 TEVA Osteoarthritis Pain Drugs Products Offered
12.23.5 TEVA Recent Development
12.24 Iroko Pharmaceuticals
12.24.1 Iroko Pharmaceuticals Corporation Information
12.24.2 Iroko Pharmaceuticals Business Overview
12.24.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Products Offered
12.24.5 Iroko Pharmaceuticals Recent Development

13 Osteoarthritis Pain Drugs Manufacturing Cost Analysis
13.1 Osteoarthritis Pain Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Osteoarthritis Pain Drugs
13.4 Osteoarthritis Pain Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Osteoarthritis Pain Drugs Distributors List
14.3 Osteoarthritis Pain Drugs Customers

15 Market Dynamics
15.1 Osteoarthritis Pain Drugs Market Trends
15.2 Osteoarthritis Pain Drugs Drivers
15.3 Osteoarthritis Pain Drugs Market Challenges
15.4 Osteoarthritis Pain Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Osteoarthritis Pain Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Osteoarthritis Pain Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Osteoarthritis Pain Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Osteoarthritis Pain Drugs Sales (M Dose) by Region (2016-2021)
Table 5. Global Osteoarthritis Pain Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Osteoarthritis Pain Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Osteoarthritis Pain Drugs Revenue Share by Region (2016-2021)
Table 8. Global Osteoarthritis Pain Drugs Sales (M Dose) Forecast by Region (2022-2027)
Table 9. Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Osteoarthritis Pain Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Osteoarthritis Pain Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Osteoarthritis Pain Drugs Sales (M Dose) of Key Companies (2016-2021)
Table 13. Global Osteoarthritis Pain Drugs Sales Share by Company (2016-2021)
Table 14. Global Osteoarthritis Pain Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Osteoarthritis Pain Drugs Revenue Share by Company (2016-2021)
Table 16. Global Osteoarthritis Pain Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoarthritis Pain Drugs as of 2020)
Table 17. Global Osteoarthritis Pain Drugs Average Price (USD/Dose) of Key Company (2016-2021)
Table 18. Manufacturers Osteoarthritis Pain Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Osteoarthritis Pain Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Osteoarthritis Pain Drugs Sales (M Dose) by Type (2016-2021)
Table 22. Global Osteoarthritis Pain Drugs Sales Share by Type (2016-2021)
Table 23. Global Osteoarthritis Pain Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Osteoarthritis Pain Drugs Price (USD/Dose) by Type (2016-2021)
Table 25. Global Osteoarthritis Pain Drugs Sales Share by Type (2022-2027)
Table 26. Global Osteoarthritis Pain Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Osteoarthritis Pain Drugs Revenue Share by Type (2022-2027)
Table 28. Global Osteoarthritis Pain Drugs Price (USD/Dose) by Type (2022-2027)
Table 29. Global Osteoarthritis Pain Drugs Sales (M Dose) by Application (2016-2021)
Table 30. Global Osteoarthritis Pain Drugs Sales Share by Application (2016-2021)
Table 31. Global Osteoarthritis Pain Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Osteoarthritis Pain Drugs Price (USD/Dose) by Application (2016-2021)
Table 33. Global Osteoarthritis Pain Drugs Sales (M Dose) by Application (2022-2027)
Table 34. Global Osteoarthritis Pain Drugs Sales Share by Application (2022-2027)
Table 35. Global Osteoarthritis Pain Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Osteoarthritis Pain Drugs Revenue Share by Application (2022-2027)
Table 37. Global Osteoarthritis Pain Drugs Price (USD/Dose) by Application (2022-2027)
Table 38. North America Osteoarthritis Pain Drugs Sales (M Dose) by Company (2016-2021)
Table 39. North America Osteoarthritis Pain Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Osteoarthritis Pain Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Osteoarthritis Pain Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)
Table 43. North America Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Osteoarthritis Pain Drugs Sales by Type (2022-2027) & (M Dose)
Table 45. North America Osteoarthritis Pain Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)
Table 47. North America Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Osteoarthritis Pain Drugs Sales by Application (2022-2027) & (M Dose)
Table 49. North America Osteoarthritis Pain Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Osteoarthritis Pain Drugs Sales (M Dose) by Company (2016-2021)
Table 51. Europe Osteoarthritis Pain Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Osteoarthritis Pain Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Osteoarthritis Pain Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)
Table 55. Europe Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Osteoarthritis Pain Drugs Sales by Type (2022-2027) & (M Dose)
Table 57. Europe Osteoarthritis Pain Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)
Table 59. Europe Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Osteoarthritis Pain Drugs Sales by Application (2022-2027) & (M Dose)
Table 61. Europe Osteoarthritis Pain Drugs Sales Market Share by Application (2022-2027)
Table 62. China Osteoarthritis Pain Drugs Sales (M Dose) by Company (2016-2021)
Table 63. China Osteoarthritis Pain Drugs Sales Market Share by Company (2016-2021)
Table 64. China Osteoarthritis Pain Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Osteoarthritis Pain Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)
Table 67. China Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)
Table 68. China Osteoarthritis Pain Drugs Sales by Type (2022-2027) & (M Dose)
Table 69. China Osteoarthritis Pain Drugs Sales Market Share by Type (2022-2027)
Table 70. China Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)
Table 71. China Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)
Table 72. China Osteoarthritis Pain Drugs Sales by Application (2022-2027) & (M Dose)
Table 73. China Osteoarthritis Pain Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Osteoarthritis Pain Drugs Sales (M Dose) by Company (2016-2021)
Table 75. Japan Osteoarthritis Pain Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Osteoarthritis Pain Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Osteoarthritis Pain Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)
Table 79. Japan Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Osteoarthritis Pain Drugs Sales by Type (2022-2027) & (M Dose)
Table 81. Japan Osteoarthritis Pain Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)
Table 83. Japan Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Osteoarthritis Pain Drugs Sales by Application (2022-2027) & (M Dose)
Table 85. Japan Osteoarthritis Pain Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Osteoarthritis Pain Drugs Sales (M Dose) by Company (2016-2021)
Table 87. Southeast Asia Osteoarthritis Pain Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Osteoarthritis Pain Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Osteoarthritis Pain Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)
Table 91. Southeast Asia Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Osteoarthritis Pain Drugs Sales by Type (2022-2027) & (M Dose)
Table 93. Southeast Asia Osteoarthritis Pain Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)
Table 95. Southeast Asia Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Osteoarthritis Pain Drugs Sales by Application (2022-2027) & (M Dose)
Table 97. Southeast Asia Osteoarthritis Pain Drugs Sales Market Share by Application (2022-2027)
Table 98. India Osteoarthritis Pain Drugs Sales (M Dose) by Company (2016-2021)
Table 99. India Osteoarthritis Pain Drugs Sales Market Share by Company (2016-2021)
Table 100. India Osteoarthritis Pain Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Osteoarthritis Pain Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)
Table 103. India Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)
Table 104. India Osteoarthritis Pain Drugs Sales by Type (2022-2027) & (M Dose)
Table 105. India Osteoarthritis Pain Drugs Sales Market Share by Type (2022-2027)
Table 106. India Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)
Table 107. India Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)
Table 108. India Osteoarthritis Pain Drugs Sales by Application (2022-2027) & (M Dose)
Table 109. India Osteoarthritis Pain Drugs Sales Market Share by Application (2022-2027)
Table 110. Sino Biopharmaceutical Corporation Information
Table 111. Sino Biopharmaceutical Description and Business Overview
Table 112. Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. Sino Biopharmaceutical Osteoarthritis Pain Drugs Product
Table 114. Sino Biopharmaceutical Recent Development
Table 115. Chugai Pharmaceutical Corporation Information
Table 116. Chugai Pharmaceutical Description and Business Overview
Table 117. Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. Chugai Pharmaceutical Osteoarthritis Pain Drugs Product
Table 119. Chugai Pharmaceutical Recent Development
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. Pfizer Osteoarthritis Pain Drugs Product
Table 124. Pfizer Recent Development
Table 125. Mikasa Seiyaku Corporation Information
Table 126. Mikasa Seiyaku Description and Business Overview
Table 127. Mikasa Seiyaku Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. Mikasa Seiyaku Osteoarthritis Pain Drugs Product
Table 129. Mikasa Seiyaku Recent Development
Table 130. Bayer Corporation Information
Table 131. Bayer Description and Business Overview
Table 132. Bayer Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 133. Bayer Osteoarthritis Pain Drugs Product
Table 134. Bayer Recent Development
Table 135. Haohai Biological Corporation Information
Table 136. Haohai Biological Description and Business Overview
Table 137. Haohai Biological Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 138. Haohai Biological Osteoarthritis Pain Drugs Product
Table 139. Haohai Biological Recent Development
Table 140. SK Chemicals Corporation Information
Table 141. SK Chemicals Description and Business Overview
Table 142. SK Chemicals Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 143. SK Chemicals Osteoarthritis Pain Drugs Product
Table 144. SK Chemicals Recent Development
Table 145. Taisho Pharmaceutical Corporation Information
Table 146. Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 147. Taisho Pharmaceutical Description and Business Overview
Table 148. Taisho Pharmaceutical Osteoarthritis Pain Drugs Product
Table 149. Taisho Pharmaceutical Recent Development
Table 150. Zhejiang Chengyi Pharmaceutical Corporation Information
Table 151. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 152. Zhejiang Chengyi Pharmaceutical Description and Business Overview
Table 153. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product
Table 154. Zhejiang Chengyi Pharmaceutical Recent Development
Table 155. Freda Corporation Information
Table 156. Freda Description and Business Overview
Table 157. Freda Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 158. Freda Osteoarthritis Pain Drugs Product
Table 159. Freda Recent Development
Table 160. Bright Future Corporation Information
Table 161. Bright Future Description and Business Overview
Table 162. Bright Future Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 163. Bright Future Osteoarthritis Pain Drugs Product
Table 164. Bright Future Recent Development
Table 165. Jingfeng Pharmaceutical Corporation Information
Table 166. Jingfeng Pharmaceutical Description and Business Overview
Table 167. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 168. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product
Table 169. Jingfeng Pharmaceutical Recent Development
Table 170. Seikagaku Corporation Corporation Information
Table 171. Seikagaku Corporation Description and Business Overview
Table 172. Seikagaku Corporation Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 173. Seikagaku Corporation Osteoarthritis Pain Drugs Product
Table 174. Seikagaku Corporation Recent Development
Table 175. GSK Corporation Information
Table 176. GSK Description and Business Overview
Table 177. GSK Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 178. GSK Osteoarthritis Pain Drugs Product
Table 179. GSK Recent Development
Table 180. Sanofi Corporation Information
Table 181. Sanofi Description and Business Overview
Table 182. Sanofi Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 183. Sanofi Osteoarthritis Pain Drugs Product
Table 184. Sanofi Recent Development
Table 185. Crystal Genomics Corporation Information
Table 186. Crystal Genomics Description and Business Overview
Table 187. Crystal Genomics Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 188. Crystal Genomics Osteoarthritis Pain Drugs Product
Table 189. Crystal Genomics Recent Development
Table 190. Johnson & Johnson Corporation Information
Table 191. Johnson & Johnson Description and Business Overview
Table 192. Johnson & Johnson Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 193. Johnson & Johnson Osteoarthritis Pain Drugs Product
Table 194. Johnson & Johnson Recent Development
Table 195. GlaxoSmithKline Corporation Information
Table 196. GlaxoSmithKline Description and Business Overview
Table 197. GlaxoSmithKline Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 198. GlaxoSmithKline Osteoarthritis Pain Drugs Product
Table 199. GlaxoSmithKline Recent Development
Table 200. Mylan Corporation Information
Table 201. Mylan Description and Business Overview
Table 202. Mylan Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 203. Mylan Osteoarthritis Pain Drugs Product
Table 204. Mylan Recent Development
Table 205. Lilly Corporation Information
Table 206. Lilly Description and Business Overview
Table 207. Lilly Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 208. Lilly Osteoarthritis Pain Drugs Product
Table 209. Lilly Recent Development
Table 210. Abbott Laboratories Corporation Information
Table 211. Abbott Laboratories Description and Business Overview
Table 212. Abbott Laboratories Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 213. Abbott Laboratories Osteoarthritis Pain Drugs Product
Table 214. Abbott Laboratories Recent Development
Table 215. Almatica Pharma Corporation Information
Table 216. Almatica Pharma Description and Business Overview
Table 217. Almatica Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 218. Almatica Pharma Osteoarthritis Pain Drugs Product
Table 219. Almatica Pharma Recent Development
Table 220. TEVA Corporation Information
Table 221. TEVA Description and Business Overview
Table 222. TEVA Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 223. TEVA Osteoarthritis Pain Drugs Product
Table 224. TEVA Recent Development
Table 225. Iroko Pharmaceuticals Corporation Information
Table 226. Iroko Pharmaceuticals Description and Business Overview
Table 227. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 228. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product
Table 229. Iroko Pharmaceuticals Recent Development
Table 230. Production Base and Market Concentration Rate of Raw Material
Table 231. Key Suppliers of Raw Materials
Table 232. Osteoarthritis Pain Drugs Distributors List
Table 233. Osteoarthritis Pain Drugs Customers List
Table 234. Osteoarthritis Pain Drugs Market Trends
Table 235. Osteoarthritis Pain Drugs Market Drivers
Table 236. Osteoarthritis Pain Drugs Market Challenges
Table 237. Osteoarthritis Pain Drugs Market Restraints
Table 238. Research Programs/Design for This Report
Table 239. Key Data Information from Secondary Sources
Table 240. Key Data Information from Primary Sources
List of Figures
Figure 1. Osteoarthritis Pain Drugs Product Picture
Figure 2. Global Osteoarthritis Pain Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Osteoarthritis Pain Drugs Sales Market Share by Application in 2021 & 2027
Figure 6. Medical Care Examples
Figure 7. Personal Care Examples
Figure 8. Global Osteoarthritis Pain Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Osteoarthritis Pain Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Osteoarthritis Pain Drugs Sales (M Dose) Growth Rate (2016-2027)
Figure 11. Global Osteoarthritis Pain Drugs Price Trends Growth Rate (2016-2027) (USD/Dose)
Figure 12. Global Osteoarthritis Pain Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Osteoarthritis Pain Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Osteoarthritis Pain Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Osteoarthritis Pain Drugs Sales (M Dose) Growth Rate (2016-2027)
Figure 16. Europe Osteoarthritis Pain Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Osteoarthritis Pain Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Osteoarthritis Pain Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Osteoarthritis Pain Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Osteoarthritis Pain Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Osteoarthritis Pain Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Osteoarthritis Pain Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Osteoarthritis Pain Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Osteoarthritis Pain Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Osteoarthritis Pain Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Osteoarthritis Pain Drugs Players Market Share by Revenue in Osteoarthritis Pain Drugs: 2016 & 2020
Figure 27. Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Osteoarthritis Pain Drugs Revenue Share by Type (2016-2021)
Figure 29. Global Osteoarthritis Pain Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Osteoarthritis Pain Drugs Revenue Share by Application (2016-2021)
Figure 31. Global Osteoarthritis Pain Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Osteoarthritis Pain Drugs Sales Market Share by Type in 2020
Figure 33. North America Osteoarthritis Pain Drugs Sales Market Share by Application in 2020
Figure 34. Europe Osteoarthritis Pain Drugs Sales Market Share by Type in 2020
Figure 35. Europe Osteoarthritis Pain Drugs Sales Market Share by Application in 2020
Figure 36. China Osteoarthritis Pain Drugs Sales Market Share by Type in 2020
Figure 37. China Osteoarthritis Pain Drugs Sales Market Share by Application in 2020
Figure 38. Japan Osteoarthritis Pain Drugs Sales Market Share by Type in 2020
Figure 39. Japan Osteoarthritis Pain Drugs Sales Market Share by Application in 2020
Figure 40. Southeast Asia Osteoarthritis Pain Drugs Sales Market Share by Type in 2020
Figure 41. Southeast Asia Osteoarthritis Pain Drugs Sales Market Share by Application in 2020
Figure 42. India Osteoarthritis Pain Drugs Sales Market Share by Type in 2020
Figure 43. India Osteoarthritis Pain Drugs Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Osteoarthritis Pain Drugs
Figure 46. Manufacturing Process Analysis of Osteoarthritis Pain Drugs
Figure 47. Osteoarthritis Pain Drugs Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed